– and with 2024 1H Performance Growing Strongly – Everest Medicines Showcasing its Industry LeadershipRecently, Everest Medicines has announced another positive development.…
Browsing: Pharma
Supporting patient comfort, improved diagnostics, and streamlined workflow, available in Europe, parts of Asia and Oceania Olympus Corporation (Olympus), a…
GEN Pharmaceuticals (GENIL.IS), a leading Turkish pharmaceutical company, has announced the positive results of its Phase 2 clinical trial evaluating…
At the start of 2024, DEXIS introduced its digital ecosystem, a suite of tools and software designed to connect and streamline the…
Unified Visualization with True 4K Imaging and 4K Narrow Band Imaging as well as blue light observation Olympus Corporation (Olympus), a…
– Collaboration to leverage AbbVie’s eye care expertise and Ripple’s innovative drug delivery platform to develop next-generation sustained release drug…
Cordlife Group Limited (“Cordlife” or the “Company” and together with its subsidiaries, the “Group”), which has been approved to resume…
Highlighting Benefits of Berberine Ursodeoxycholate (HTD1801) HighTide Therapeutics, Inc. (HKG: 2511), a clinical stage biopharmaceutical company specializing in the development…
Pet food consumes at least 9% of all livestock globally, rising to 20% in nations such as the US with…
The last few years have been tumultuous, marked by rising inflation, job market fluctuations and housing market volatilities, among other…
– Multi-Dimensional Synergy to Empower High-Quality Development Beijing Tong Ren Tang Chinese Medicine Company Limited (Tong Ren Tang Chinese Medicine…
On 28 August 2024, Fosun International (HKG: 0656) announced its 2024 interim results. During the reporting period, its revenue continued…
– Dorzagliatin (trade name: HuaTangNing, world’s first dual-acting glucokinase activator (GKA), successfully entered China’s National Reimbursement Drug List for Basic…
– Product Innovation + Model Innovation Achieves Remarkable Results to Create New Quality Productive Forces – Focuses on ‘AI +…
Moderna, Inc. (NASDAQ:MRNA) today announced that it has received approval from the Ministry of Health, Labour and Welfare (MHLW) in Japan…
Recognition of Avantor’s achievements in downstream processing, single-use systems, and its overall leadership as a biopharma supplier in Korea. Avantor,…
– for Personalized mRNA Cancer Vaccine Program EVM16 Everest Medicines (HKG: 1952, Everest, or the Company), a biopharmaceutical company focused…
– Robust R&D Pipeline Drives Continued Commercial Progress – Efficient Integration of Acquired Assets Supports Long-Term Growth Trajectory Results Highlights:…
PanMediso Holdings’ international team completes core technology verification for mass production of Ac-225 PanMediso Holdings (Shenzhen) Limited, with the collaborative…
– Addition of third MRI scanner in 4Q 2023 and set-up of new diagnostic imaging centre expected to nearly double…